
TWO NOVEL CEBPA MUTATIONS IN A TURKISH PATIENT
WITH ACUTE MYELOID LEUKEMIA Tokgun PE, Alay MT, Atli Tekin S, Güler N, Tokgun O, Demiray A,
Karagenc N, Durak T, Celik B, Akca H *Corresponding Author: Professor Hakan Akca, Department of Medical Genetics, School of Medicine,
Pamukkale University, Çamlaraltı, Denizli, Turkey 20070. Tel.: +90-258-296-48-04. Fax: +90-258-296-
17-65. E-mail: hakca@pau.edu.tr page: 99
|
MATERIALS AND METHODS
Genomic DNA from peripheral blood was prepared
by using QIAamp DNA Blood Mini Kit (Qiagen, Hilden,
Germany). The polymerase chain reaction (PCR) conditions
using the following primers (Table 1) were as follows:
initial denaturation at 94 °C for 5 min. followed by
35 cycles at 94 °C for 30 seconds, 58 °C for 30 seconds,
72 °C for 1 min., followed by 5 min. at 72 °C. Sequencing
reactions were carried out using BigDye Terminator
v 3.1 cycle sequencing kit (Applied Biosystems, Foster
City, CA, USA) as follows: an initial denaturation at 96
°C for 1 min., then 25 cycles at 96 °C for 10 seconds, 50
°C for 5 seconds, 60 °C for 4 min., followed by 1 min. at
72 °C. Final purification was acquired using Sephadex.
The ABI PRISM® 3130 genetic analyzer (Applied Biosystems)
was used for capillary electrophoresis. The all
somatic and germline mutations are defined in line with
the guidelines of the Human Genome Variation Society
(HGVS). Mutations, variations and expressional activities
were checked using in silico algorithm based databases
as Clinvar (https:// www.ncbi.nlm.nih.gov/clinvar/), MutationTaster
(http:// www.mutationtaster.org/), Varsome
(https://varsome. com/), dbSNP [a database of single
nucleotide polymorphisms (SNP)] (http://ncbi.nlm. nih.
gov/snp).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|